Quest for the right Drug
ספקטרצף 400 מ"ג SPECTRACEF 400 MG (CEFDITOREN AS PIVOXIL)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
טבליות מצופות פילם : FILM COATED TABLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Approximately 6000 patients received cefditoren at either 200 mg or 400 mg twice daily for up to 14 days in clinical trials. About 24% of patients reported at least one adverse reaction. Treatment discontinuation as a consequence of adverse reactions occurred in 2.6% of the patients. The most commonly occurring adverse reactions were gastrointestinal events. In most studies, diarrhoea occurred in more than 10% of all patients and was more common with 400 mg than with 200 mg twice daily. The observed adverse reactions, reported either during clinical trials or post-marketing experience, are described below: Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Very Common Not known common Adverse Uncommon Rare Adverse (cannot be System Organ Adverse Reactions Adverse Reactions Reactions estimated from Class Reactions (≥1/100, (≥1/1,000, <1/100) (≥1/10,000, <1/1,000) the available (≥1/10) <1/10) data) Prolonged coagulation time, increased AST, increased alkaline phosphatase, Leukopenia, Serum carnitine Investigations albuminuria, increased ALT decreased thromboplastin time decrease, increased LDH, and increased creatinine Atrial fibrillation, heart failure, syncope, Cardiac disorders tachycardia, ventricular extrasystole Eosinophilia, Blood and the neutropenia Thrombocytosis, lymphatic system trombocytopenia, Agranulocytosis leukopenia disorders haemolytic anaemia, lymphadenopathy Nervousness, Amnesia, dizziness, Nervous system discoordination, Headache insomnia, disorders hypertonia, meningitis, somnolence, sleep tremor disorders Amblyopia, eye Eye disorders disorder, eye pain, blepharitis Ear and labyrinth Tinnitus disorders Respiratory, Eosinophilic thoracic and Pharyngitis, pneumonia, Asthma mediastinal rhinitis, sinusitis interstitial disorders pneumonia Stomatitis, Constipation, mouth ulcers, Nausea, flatulence, haemorrhagic colitis, Gastrointestinal abdominal vomiting, oral ulcerative colitis, Diarrhoea disorders pain, candidiasis, gastrointestinal dyspepsia eructation, dry haemorrhage, glossitis, mouth, dysgeusia hiccup, discoloured tongue Dysuria, pain in the renal cavity, nephritis, Renal and urinary nycturia, polyuria, Acute renal failure disorders incontinence, albuminuria Stevens Johnson Acne, alopecia, eczema, syndrome, Skin and exfoliative dermatitis, Rash, pruritus, erythema subcutaneous herpes simplex, urticaria multiforme, toxic tissue disorders photosensitivity epidermal reaction necrolysis Musculoskeletal, connective tissue Myalgia disorders Very Common Not known common Adverse Uncommon Rare Adverse (cannot be System Organ Adverse Reactions Adverse Reactions Reactions estimated from Class Reactions (≥1/100, (≥1/1,000, <1/100) (≥1/10,000, <1/1,000) the available (≥1/10) <1/10) data) Dehydration, Metabolism and hyperglycemia, Anorexia nutrition disorders hypokalemia, hypoproteinemia Urinary tract infection, Infections and Vaginal Fungal infection Clostridium difficile infestations candidiasis diarrhoea Vascular Postural hypotension disorders General disorders and Fever, asthenia, Body odour, chills administration site pain, sweating conditions Anaphylactic Immune system shock, serum disorders sickness disease Hepato-biliary Hepatic function Liver injury, Bilirubinemia disorders abnormal Hepatitis Reproductive Mastalgia, menstrual Vaginitis, systems and disorders, metrorrhagia, leukorrhea breast disorders erectile dysfunction Dementia, depersonalisation, emotional weakness, Psychiatric euphoria, disorders hallucinations, thinking disorders, increased libido The following adverse reactions could appear since they have been observed with other cephalosporins: cholestasis and aplastic anaemia. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form: https://sideeffects.health.gov.il
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף